Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
08/31/2000 | WO2000050586A2 In vitro translation system |
08/31/2000 | WO2000050585A1 Novel adc polynucleotides and polypeptides, uses thereof including methods for improving seeds |
08/31/2000 | WO2000050581A2 Isolation and characterization of a n. crassa silencing gene and uses thereof |
08/31/2000 | WO2000050567A1 Fungal cells with inactivated dna mismatch repair system |
08/31/2000 | WO2000050566A2 Genes encoding insect odorant receptors and uses thereof |
08/31/2000 | WO2000050565A2 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene |
08/31/2000 | WO2000050563A2 G protein-coupled receptor resembling galanin receptors |
08/31/2000 | WO2000050562A2 Dna encoding snorf25 receptor |
08/31/2000 | WO2000050561A2 CaESS1: A CANDIDA ALBICANS GENE, METHODS OF MAKING AND USE |
08/31/2000 | WO2000050460A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses |
08/31/2000 | WO2000050459A1 Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2 |
08/31/2000 | WO2000050458A1 Cloning of a p2y-like 7tm receptor (axor17) |
08/31/2000 | WO2000050457A1 Prostate-specific membrane antigens and methods of making and using |
08/31/2000 | WO2000050456A2 Covalently bridged insulin dimers |
08/31/2000 | WO2000050455A2 Antigen to systemic lupus erythematosis and diagnostic assay |
08/31/2000 | WO2000050454A1 Androgen-induced suppressor of cell proliferation and uses thereof |
08/31/2000 | WO2000050453A1 A novel inhibitor of programmed cell death |
08/31/2000 | WO2000050452A1 Mutants of rac protein |
08/31/2000 | WO2000050451A2 Protein (tp) that is involved in the development of the nervous system |
08/31/2000 | WO2000050450A1 Mite protein |
08/31/2000 | WO2000050449A1 Process for production diphtheria toxin |
08/31/2000 | WO2000050448A1 A method for controlling an enzymatic reaction by the alpha and beta domains of metallothionein |
08/31/2000 | WO2000050445A1 Novel component of von hippel-lindau tumor suppressor complex and scf ubiquitin ligase |
08/31/2000 | WO2000050444A1 Bk beta subunits of slo family potassium channels |
08/31/2000 | WO2000050443A2 Secreted proteins and uses thereof |
08/31/2000 | WO2000050442A2 Secreted proteins and uses thereof |
08/31/2000 | WO2000050435A1 tktA |
08/31/2000 | WO2000050433A2 Staphylococcus aureus q13 polynucleotides, polypeptides and methods of use |
08/31/2000 | WO2000050087A1 Glycoconjugates obtained from candida utilis cells and ricinus communis seeds |
08/31/2000 | WO2000050077A1 Immunogens comprising a peptide and a carrier derived from h.influenzae protein d |
08/31/2000 | WO2000050076A1 Adenoviral vectors, proteins and methods for their use |
08/31/2000 | WO2000050075A2 Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs |
08/31/2000 | WO2000050074A2 Neisserial vaccine compositions and methods |
08/31/2000 | WO2000050071A1 PROTEIN OmpA OF KLEBSIELLA PNEUMONIAE ASSOCIATED WITH THE HCG HORMONE OR A COMPOUND INVOLVED IN CELL PROLIFERATION OR FERTILITY |
08/31/2000 | WO2000050062A2 Methods and compositions for altering mucus secretion |
08/31/2000 | WO2000050044A1 Vaccine for house dust mite allergen using naked plasmid dna |
08/31/2000 | WO2000049937A2 Trpm-2 antisense therapy |
08/31/2000 | WO2000049871A1 An anti-angiogenic kringle protein and its mutants |
08/31/2000 | WO2000049867A2 Synthesis of the first paramagnetic and active analogue (epm-2) of the melanocyte stimulating hormone |
08/31/2000 | WO2000049862A1 Transgenic mollusc and method for constructing the same |
08/31/2000 | WO2000043492A8 Method of site specific labeling of proteins and uses therefor |
08/31/2000 | WO2000032632A3 Allo- and auto-reactive t-cell epitopes from rhesus protein and their use |
08/31/2000 | WO2000028834A3 Method for reducing the viscosity of aqueous protein concentrates with polyols |
08/31/2000 | WO2000028079A3 Genetic variation associated with aplastic anemia, and diagnosis and therapy based thereon |
08/31/2000 | WO2000028040A3 Cloning of rhadinovirus genome and methods for its use |
08/31/2000 | WO2000028038A3 Virulence genes and proteins, and their use |
08/31/2000 | WO2000028029A3 Cell surface glycoproteins |
08/31/2000 | WO2000028023A3 Ischaemia/reperfusion-inducible dna's and proteins |
08/31/2000 | WO2000026236A3 Method of modulating cell differentiation or neoplastic transformation by altering cadherin-11 expression or function |
08/31/2000 | WO2000025805A8 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2 |
08/31/2000 | WO2000024903A3 Plant-optimized polynucleotides encoding pesticidal 43f- and 80jj1/130-type proteins |
08/31/2000 | WO2000023472A3 Interferon-beta fusion proteins and uses |
08/31/2000 | WO2000022128A9 Protein conjugates containing multimers of green fluorescent protein |
08/31/2000 | WO2000021548A3 Angiogenically effective unit dose of fgf and method of administering |
08/31/2000 | WO2000020584A9 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6 |
08/31/2000 | WO2000018932A9 Receptor based antagonists and methods of making and using |
08/31/2000 | WO2000018923A9 Slgp protein and nucleic acid molecule and uses therefor |
08/31/2000 | WO2000018914A3 Novel dkr polypeptides |
08/31/2000 | WO2000018910A9 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
08/31/2000 | WO2000018906A9 Shuffling of codon altered genes |
08/31/2000 | WO2000018904A9 Secreted proteins and nucleic acids encoding them |
08/31/2000 | WO2000018803A3 Antibodies to mammalian langerhans cell antigen and their uses |
08/31/2000 | WO2000018795A9 Compositions and methods for wt1 specific immunotherapy |
08/31/2000 | WO2000014237A3 17 kDa FOAM PROTEIN |
08/31/2000 | WO2000011200A3 Plant expression vectors |
08/31/2000 | WO2000009657A3 Methods of modulating of angiogenesis |
08/31/2000 | DE19908766A1 New synthetic peptides from the Vpr protein of human immune deficiency virus, useful e.g. for therapy and diagnosis, have good solubility in water |
08/31/2000 | DE19908752A1 New synthetic peptides from the Vpr protein of human immune deficiency virus, useful e.g. for therapy and diagnosis, have good solubility in water |
08/31/2000 | DE19908423A1 An der Entwicklung des ZNS beteiligtes Protein (TP) The development of the CNS involved protein (TP) |
08/31/2000 | DE19908041A1 Kovalent verbrückte Insulindimere Covalently bridged insulin dimers |
08/31/2000 | DE19858005A1 Synthetisches Nucleinsäure-Partikel Synthetic nucleic acid particles |
08/31/2000 | CA2850318A1 Trpm-2 antisense therapy |
08/31/2000 | CA2371928A1 Neisserial vaccine compositions and methods |
08/31/2000 | CA2371814A1 Trpm-2 antisense therapy |
08/31/2000 | CA2366951A1 Methods and compositions for altering mucus secretion |
08/31/2000 | CA2365101A1 Beta-tubulin autoantibody in meniere's disease and other inner ear diseases and a diagnostic method |
08/31/2000 | CA2365026A1 Virus vector |
08/31/2000 | CA2364988A1 G protein-coupled receptor resembling galanin receptors |
08/31/2000 | CA2364966A1 Genes encoding insect odorant receptors and uses thereof |
08/31/2000 | CA2364925A1 Monkey gonadotropin releasing hormone receptor |
08/31/2000 | CA2364921A1 Translation system |
08/31/2000 | CA2363829A1 Haemophilus antigen |
08/31/2000 | CA2363816A1 Dna sequence of a protein that is similar to fkbp |
08/31/2000 | CA2363794A1 14273 receptor, a novel g-protein coupled receptor |
08/31/2000 | CA2363779A1 Human endokine alpha and methods of use |
08/31/2000 | CA2363707A1 Nucleic acid and amino acid sequences of hemoglobin-response genes in candida albicans and the use of reagents derived from these sequences in the diagnosis of disseminated candida albicans infection |
08/31/2000 | CA2363704A1 Expressing gp140 fragment of primary hiv-1 isolate |
08/31/2000 | CA2363637A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses |
08/31/2000 | CA2363626A1 Bk beta subunits of slo family potassium channels |
08/31/2000 | CA2363621A1 A novel inhibitor of programmed cell death |
08/31/2000 | CA2363605A1 Androgen-induced suppressor of cell proliferation and uses thereof |
08/31/2000 | CA2363599A1 Novel adc polynucleotides and polypeptides, uses thereof including methods for improving seeds |
08/31/2000 | CA2363118A1 Immunogens comprising a peptide and a carrier derived from h.influenzae protein d |
08/31/2000 | CA2363112A1 Neutrokine-alpha and neutrokine-alpha splice variant |
08/31/2000 | CA2363106A1 Mdm interacting protein and methods of use thereof |
08/31/2000 | CA2363095A1 Glycoconjugates obtained from candida utilis cells and ricinus communis seeds |
08/31/2000 | CA2362928A1 Vaccine for house dust mite allergen using naked plasmid dna |
08/31/2000 | CA2362906A1 Dna encoding snorf25 receptor |
08/31/2000 | CA2362608A1 Compounds and methods for the detection and prevention of t. cruzi infection |
08/31/2000 | CA2362520A1 Novel component of von hippel-lindau tumor suppressor complex and scf ubiquitin ligase |